David MD - Cue Health Chief Officer
Executive
David MD is Chief Officer of Cue Health
Phone | 858 412 8151 |
Web | https://www.cuehealth.com |
Cue Health Management Efficiency
The company has return on total asset (ROA) of (0.308) % which means that it has lost $0.308 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9457) %, meaning that it created substantial loss on money invested by shareholders. Cue Health's management efficiency ratios could be used to measure how well Cue Health manages its routine affairs as well as how well it operates its assets and liabilities.Cue Health currently holds 47.94 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cue Health has a current ratio of 2.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cue Health's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Kevin OHara | HealthStream | 54 | |
Kevin Scharnhorst | Health Catalyst | N/A | |
Michael Campana | Healthcare Triangle | N/A | |
Damian David | Healthcare Triangle | N/A | |
Joseph Machicote | Premier | N/A | |
Steve Lindsay | HealthEquity | N/A | |
Leslie Falk | Health Catalyst | N/A | |
Arthur Newman | HealthStream | 76 | |
Laurie Graham | Premier | N/A | |
Lisa Benna | Premier | N/A | |
Frederic Bois | Certara | N/A | |
Jason Holden | Forian Inc | N/A | |
Yew CPA | EUDA Health Holdings | 56 | |
Holly Rimmasch | Health Catalyst | N/A | |
Jason Hahn | National Research Corp | 52 | |
Tia Padia | HealthEquity | N/A | |
Benjamin Landry | Health Catalyst | 42 | |
Kevin Freeman | Health Catalyst | 51 | |
Tarah Bryan | Health Catalyst | N/A | |
Scott Fenstermacher | HealthStream | 56 | |
Linda Stacy | National Research Corp | 54 |
Management Performance
Return On Equity | -0.95 | |||
Return On Asset | -0.31 |
Cue Health Leadership Team
Elected by the shareholders, the Cue Health's board of directors comprises two types of representatives: Cue Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cue. The board's role is to monitor Cue Health's management team and ensure that shareholders' interests are well served. Cue Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cue Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Erica Esq, General Secretary | ||
Lorna Williams, Vice Relations | ||
Allison Blackwell, Chief Officer | ||
David Arida, Chief Officer | ||
Ayub Khattak, President, CoFounder | ||
Nitin Duggal, Chief Officer | ||
John Gallagher, Chief Officer | ||
Dena Cook, Chief Officer | ||
Clint Sever, CoFounder Officer | ||
Aasim Javed, Treasurer CFO | ||
Eileen Sheil, Chief Officer | ||
Randall Pollard, Controller Officer | ||
David MD, Chief Officer | ||
Christopher Achar, Chief Director | ||
Suzanne Stone, Chief Officer |
Cue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cue Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.95 | |||
Return On Asset | -0.31 | |||
Operating Margin | (4.38) % | |||
Current Valuation | 5.46 M | |||
Shares Outstanding | 159.09 M | |||
Shares Owned By Insiders | 11.56 % | |||
Shares Owned By Institutions | 52.80 % | |||
Number Of Shares Shorted | 776.46 K | |||
Price To Earning | 16.86 X | |||
Price To Book | 0.10 X |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Cue Stock
If you are still planning to invest in Cue Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cue Health's history and understand the potential risks before investing.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |